ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $21,041 | -96.5% | 41,257 | -88.2% | 0.00% | -100.0% |
Q3 2022 | $602,000 | +6588.9% | 349,867 | +4589.3% | 0.00% | – |
Q2 2022 | $9,000 | -69.0% | 7,461 | -82.9% | 0.00% | – |
Q1 2022 | $29,000 | -82.6% | 43,707 | -71.5% | 0.00% | -100.0% |
Q4 2021 | $167,000 | +595.8% | 153,618 | +1072.0% | 0.00% | – |
Q3 2021 | $24,000 | -73.9% | 13,107 | -62.4% | 0.00% | -100.0% |
Q2 2021 | $92,000 | -47.1% | 34,835 | -28.0% | 0.00% | -50.0% |
Q1 2021 | $174,000 | +39.2% | 48,394 | -2.4% | 0.00% | 0.0% |
Q4 2020 | $125,000 | -27.7% | 49,575 | -28.0% | 0.00% | -33.3% |
Q3 2020 | $173,000 | +408.8% | 68,817 | +568.1% | 0.00% | +200.0% |
Q2 2020 | $34,000 | -76.9% | 10,300 | -82.9% | 0.00% | -75.0% |
Q1 2020 | $147,000 | -73.9% | 60,161 | -37.8% | 0.00% | -60.0% |
Q2 2019 | $564,000 | +652.0% | 96,717 | +715.2% | 0.01% | +100.0% |
Q1 2017 | $75,000 | -34.2% | 11,864 | -43.1% | 0.01% | -28.6% |
Q2 2016 | $114,000 | +225.7% | 20,850 | +619.2% | 0.01% | +250.0% |
Q2 2015 | $35,000 | -76.5% | 2,899 | -79.1% | 0.00% | -71.4% |
Q1 2015 | $149,000 | – | 13,864 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Belmont Global Advisors, Inc. | 2,564,925 | $11,132,000 | 8.99% |
Essex Woodlands Management, Inc. | 2,764,908 | $11,330,000 | 5.70% |
Third Security, LLC | 17,815,708 | $77,320,000 | 3.68% |
MSD Partners, L.P. | 2,750,000 | $11,935,000 | 0.49% |
SFMG, LLC | 99,850 | $433,000 | 0.15% |
GM Advisory Group, LLC | 12,500 | $54,000 | 0.06% |
Geduld E E | 25,000 | $109,000 | 0.05% |
WESTPORT RESOURCES MANAGEMENT INC | 30,500 | $132,000 | 0.04% |
Janney Montgomery Scott LLC | 335,571 | $1,456,378,000 | 0.04% |
WFG Advisors, LP | 48,040 | $208,000 | 0.03% |